General Federal Contracts — June 12, 2026

Partner Therapeutics, a small business, secured a firm-fixed-price delivery order from HHS/ASPR for Leukine, with $83.5M already outlaid. This provides multi-year revenue visibility through March 2027 and suggests sustained government investment in pharmaceutical stockpiles.

The Department of State awarded CADDELL a $322.4M firm-fixed-price contract for the Rio New Consulate Compound. Fixed-price construction projects of this magnitude expose the contractor to cost overruns, especially with a 4.6-year performance period through February 2027.

MANTECH won a 7.5-year cost-plus-fixed-fee contract worth $452M from GSA FEDSIM for R&D services. The long duration and cost-plus pricing reduce margin risk, making this a stable revenue contributor for MANTECH INTERNATIONAL CORPORATION.

JAG KETCHIKAN, a small business, won a $99.6M firm-fixed-price contract from NOAA for ship modernization. The fixed-price structure transfers risk to the contractor, and the small business may lack the financial buffer to absorb significant cost overruns.

MAXIMUS won a $92.3M firm-fixed-price BPA call from the IRS, but only $30.6M has been outlayed. This suggests the contract is in early execution or subject to budget uncertainty, potentially limiting near-term revenue recognition.

CADDELL Construction's $322M firm-fixed-price consulate contract in Rio carries significant execution risk due to fixed-price structure and complex international construction. Cost overruns could materially impact margins.

JAG KETCHIKAN, a small business, faces execution risk on a $99.6M firm-fixed-price ship modernization contract. Small businesses often have thinner margins and less capacity to absorb cost overruns on complex maritime projects.

MAXIMUS Federal Services' $92.3M IRS contract has only $30.6M outlayed (33%), suggesting phased funding that could be vulnerable to budget cuts or continuing resolutions. The IRS's IT modernization budget may face political headwinds.

The digest is heavily concentrated in civilian agencies (90% of total value), with only one defense-related contract. This limits exposure to defense budget growth and NDAA priorities, which are typically more durable.

All contracts were awarded under full and open competition with no set-asides, indicating no preferential treatment. This means incumbents face re-compete risk and potential margin compression from competitive bidding.

MANTECH's $452M GSA R&D contract through 2027 provides a stable, multi-year revenue base. The cost-plus-fixed-fee structure ensures predictable margins, and the long duration supports organic growth in MANTECH's government services segment.

Partner Therapeutics' $133.5M HHS delivery order for Leukine signals growing government investment in medical countermeasures. This could lead to follow-on contracts for pharmaceutical preparedness, benefiting the broader biodefense sector.

MAXIMUS Federal Services' $92.3M IRS IT modernization contract positions the company for further civilian agency IT work. The IRS's continued investment in tax administration technology could lead to additional task orders or follow-on contracts.

The digest's 90% civilian concentration highlights a potential opportunity for defense-focused contractors to capture civilian agency work. Companies like SAIC and MANTECH with dual-use capabilities could leverage their defense expertise for civilian IT modernization contracts.

Multiple contracts in this digest support civilian agency IT modernization, including MANTECH's $452M GSA R&D award, MAXIMUS's $92.3M IRS IT systems contract, and PERATON's $121.6M GSA application development support. This suggests sustained government investment in upgrading legacy IT systems across civilian agencies.

Three contracts totaling $386.4M are tied to HHS, including Partner Therapeutics' $133.5M Leukine delivery order, ACUMEN's $167.3M CMS consulting contract, and CTIS's $85.6M NIH cancer IT support. This indicates stable to growing funding for health IT, medical countermeasures, and research support.

Two large construction contracts—CADDELL's $322M State Department consulate and JAG KETCHIKAN's $99.6M NOAA ship modernization—signal continued government investment in physical infrastructure, including diplomatic facilities and maritime research assets.

{"entity"=>"MANTECH INTERNATIONAL CORPORATION", "reason"=>"Won the largest contract in the digest ($452M GSA R&D) with multi-year revenue visibility through 2027. Key to watch for option exercises and follow-on task orders.", "trigger"=>"Option exercise announcements or new GSA FEDSIM awards"}

{"entity"=>"PARTNER THERAPEUTICS, INC.", "reason"=>"Only bullish signal in the digest with a $133.5M HHS delivery order for Leukine. As a private company, any IPO or acquisition would create a public investment vehicle.", "trigger"=>"IPO filing, acquisition announcement, or new HHS procurement for Leukine"}

{"entity"=>"MAXIMUS FEDERAL SERVICES, INC.", "reason"=>"$92.3M IRS IT contract with only 33% outlayed. Full exercise of options or new task orders would signal strong execution and budget stability.", "trigger"=>"Option exercise announcements or IRS IT budget updates"}

{"entity"=>"CADDELL CONSTRUCTION CO. (DE), LLC", "reason"=>"High execution risk on $322M firm-fixed-price consulate contract. Cost overruns could materially impact the company's financials.", "trigger"=>"Quarterly earnings reports, contract modifications, or cost overrun disclosures"}

{"entity"=>"JAG KETCHIKAN, LLC", "reason"=>"Small business with $99.6M firm-fixed-price ship modernization contract. Execution risk is high given the complexity and fixed-price structure.", "trigger"=>"Progress reports on NOAA Ship Henry B. Bigelow, cost overrun disclosures"}